Comparison of active treatments for impaired glucose regulation: a Salford Royal Foundation Trust and Hitachi collaboratio

Not Applicable

Completed

• Conditions: Impaired glucose regulation; Nutritional, Metabolic, Endocrine; Prediabetes

• Registration Number: ISRCTN16534814
• Lead Sponsor: niversity of Manchester

Brief Summary

2016 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/27561822 2019 results in https://pubmed.ncbi.nlm.nih.gov/31304355/ (added 26/04/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-07-02
• Study Completion: 2016-08-31
• Last Update Posted: 10 May 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 209

Inclusion Criteria

1. IGR confirmed by HbA1c between 42-47 mmol/ml in last 6 months
2. Access to a telephone and home internet

Exclusion Criteria

1. They were referred to the face-to-face group IGR education session and do not go onto receive telephone only support
2. They are already diagnosed with type 2 diabetes
3. They have gestational diabetes
4. They are aged less than 18 years old
5. They refuse consent
6. They have no English
7. Their GP considers them incapable of participating (e.g. dementia, learning difficulties, vision or motor skills limitations)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Client Satisfaction Questionnaire (self-reported questionnaire) at baseline and at 9-month follow-up

Secondary Outcome Measures

Name	Time	Method
<br> Health outcomes:<br> Change in HbA1c, weight (kg), and BMI (from baseline to follow-up at 9 months), Quality of life (self reported EQ-5D), mental health (Mental Health Inventory-5)<br><br> Health experience and self-management:<br> Summary of Diabetes Self-Care Activities (SDSCA), Patient Activation Measure (PAM)<br><br> Direct costs of delivery of intervention<br>